Radiopharm Theranostics
RADX----
H1 2026 Earnings
Financial report interval: 2025.07.01 - 2025.12.31
Preview: Radiopharm Theranostics(RADX) predict that the Revenue is 658.57 K (--%), Beat estimate;the EBIT is -12.68 M (--%), Miss estimate;the EPS is -2.11 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B--
0.00B--
+0.00B--%
EBITMiss expectations
-0.01B--
-0.01B--
-0.00B--%
EPSMiss expectations
-2.1089--
-1.5204--
-0.5885--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf